Junjian Wang

18PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiologically active moleculesBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 04, 2026
Dual-Site Covalent Targeting Enables BD2-Selective BET Inhibition With Potent Antitumor Activity in Mice.

|Mar 04, 2026
Single-cell profiling of tumor lineage plasticity and the immune microenvironment in transformed small cell lung cancer.

Jie Huang, Zhenhua Zhang, Guodi Cai

|Dec 22, 2025
FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinoma.

Zhanfeng Gu, Xiaojuan Wang, Hong Wang

|Dec 09, 2025
Discovery of highly potent marine-derived compound Penicolinate H reveals SREBP-1 mediated lipogenesis as a druggable vulnerability in gastric cancer.

Jianjiao Chen, Haishan Cui, Xiaolu Wang

|Nov 27, 2025
Cytotoxic Cytochalasans from Sponge-Derived Aspergillus sp. SCSIO 41044.

Xiaoyan Pang, Ini Wong, Qinlin Cao

|Oct 23, 2025
RORγ Hijacks HIF1α to Promote Peritoneal Metastasis of Gastric Cancer.

Qianqian Wang, Lin Zhong, Xiaojuan Wang

Pageof 3

Frequent Collaborators

4 joint publications

Huihao Zhou

3 joint publications

Peiqing Liu

3 joint publications

Hong Wang

2 joint publications

Xiaoyun Lu